Evidence map›Paper›PMID 41869173›Full record

ArticleCureus2026

Atypical Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes (POEMS) Syndrome.

Micheal Bishara, Anna Homeniuk, Aayush Patel, Feras Al Moussally, Venkataraman Rajagopalan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Micheal BisharaInternal Medicine, University of Pittsburgh Medical Center Pinnacle, Harrisburg, USA.
Anna HomeniukInternal Medicine, University of Pittsburgh Medical Center Pinnacle, Harrisburg, USA.
Aayush PatelHematology and Medical Oncology, Drexel University College of Medicine, Harrisburg, USA.
Feras Al MoussallyHematology and Medical Oncology, University of Pittsburgh Medical Center Pinnacle, Harrisburg, USA.
Venkataraman RajagopalanHematology and Medical Oncology, University of Pittsburgh Medical Center Pinnacle, Harrisburg, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes (POEMS) syndrome is a rare paraneoplastic syndrome that occurs mostly in the context of lambda-restricted plasma cell disorders. Diagnosis is made when patients have certain disease-defining criteria. Atypical presentations of POEMS are suspected when patients do not meet those predefined diagnostic criteria.  An 82-year-old female patient was referred to the hematology clinic for persistent thrombocytosis. The patient had a history of stroke and was asymptomatic, and the clinical exam was noncontributory except for the presence of small axillary lymph nodes. Workup demonstrated a picture of an IgG kappa monoclonal gammopathy (MG), with an elevated serum free kappa light chain, a normal free lambda light chain, and an increased kappa/lambda ratio, prompting further evaluation for an underlying plasma cell disorder. Bone marrow biopsy showed plasma cell neoplasm at 20% to 30%. Both the karyotype and the plasma cell fluorescence in situ hybridization (FISH) prognosis panel were normal. Lymph node (LN) core needle biopsy showed follicular hyperplasia. Smoldering multiple myeloma (SMM) was considered. Due to the patient's clinical history, a diagnosis of atypical POEMS was entertained. Vascular endothelial growth factor (VEGF) was elevated. Electromyography (EMG) testing for sensory and motor conduction for lower limbs revealed abnormal findings aligning with subclinical polyneuropathy. This strongly favored the diagnosis of atypical POEMS. Initially, our patient was evaluated for an underlying plasma cell disorder, since the presence of monoclonal protein, monoclonal gammopathy of undetermined significance (MGUS), was the highest on the differential. When the bone marrow biopsy showed a 20% to 30% plasma cell infiltration, SMM was diagnosed. However, the presence of certain characteristic features for POEMS, including nodal enlargement and thrombocytosis, led to entertaining the differential diagnosis of POEMS. Markedly elevated serum VEGF levels further reinforced the diagnosis. Clinically absent neuropathy raised the concern for an atypical POEMS, but subsequently, EMG testing showed that the patient has subclinical polyneuropathy, which provided additional support for the diagnosis of atypical POEMS.  To meet the diagnosis of POEMS syndrome, challenging criteria should be fulfilled. Polyneuropathy and lambda-restricted are major criteria for the diagnosis of typical POEMS syndrome. In our case, the patient had a kappa-restricted variant and subclinical polyneuropathy, compounding this atypical POEMS presentation. This case report highlights the importance of a broad differential, including atypical presentations, while at the same time, highlighting the importance of early detection to ensure proper management for better outcomes.

Indexed as

atypical poemslambda-restricted plasma cell disordersmonoclonal gammopathymonoclonal gammopathy of undetermined significance (mgus)polyneuropathyrare case reporttypical poems

Identifiers

PMID41869173
PMCPMC13002282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.